Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-15-006808

Director acquired 4,884,755 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Canaan IX L.P. Director 2015-10-14 Conversion +4,884,755 4,884,755 I: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Canaan IX L.P. Director 2015-10-14 Conversion · Series B-1 Redeemable Convertible Preferred Stock −3,566,337 0 I: show line 2 in the form
Canaan IX L.P. Director 2015-10-14 Conversion · Series C Redeemable Convertible Preferred Stock −1,318,418 0 I: show line 3 in the form
Loading xslF345X03/doc4.xml…